MANE
Veradermics, Incorporated
Stock
$116.76−0.46 (−0.39%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$72M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$72M | — |
| 2024 | −$24M | — |
Veradermics, Incorporated
$116.76−0.46 (−0.39%)Close Oct 2, 2026
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$72M | — |
| 2024 | −$24M | — |